The Effects of Vaccine Education on Those with Cardiovascular Disease
Advisor(s)
Megan Lieb
Confirmation
1
Document Type
Poster
Location
ONU McIntosh Center; Activities Room
Start Date
11-4-2025 11:00 AM
End Date
11-4-2025 11:50 AM
Abstract
Problem: Cardiovascular disease (CVD) is a leading cause of morbidity and mortality worldwide. Individuals with CVD are at increased risk for complications from respiratory infections such as influenza and pneumonia. Influenza and pneumococcal vaccines have been shown to reduce the incidence of these infections and associated hospitalizations in CVD patients. However, vaccine compliance remains suboptimal.
Aim: This study aims to evaluate whether implementing mandatory discharge teaching on receiving the influenza and pneumococcal vaccines in patients newly diagnosed with CVD increases vaccine compliance compared to those who do not receive educational interventions.
Methods: A prospective cohort study will be conducted involving patients with a new diagnosis of CVD. Patients will be randomly assigned to either the intervention group, where mandatory discharge teaching on the importance and benefits of receiving the influenza and pneumococcal vaccines will be provided, or the control group, where no specific discharge education will be given regarding vaccination. The primary outcome is vaccine compliance, measured by documented receipt of both vaccines within three months of hospital discharge.
Conclusion: It is anticipated that patients receiving discharge education on the vaccines will show a higher rate of vaccine compliance compared to those who do not receive such education. If the intervention group shows significantly higher vaccine compliance, this would suggest that mandatory discharge teaching on influenza and pneumococcal vaccination could be a viable strategy to improve preventive care in patients with newly diagnosed CVD. As a result, potentially reducing their risk of serious respiratory infections and related complications, including mortality.
Recommended Citation
Kelley, Kensington, "The Effects of Vaccine Education on Those with Cardiovascular Disease" (2025). ONU Student Research Colloquium. 30.
https://digitalcommons.onu.edu/student_research_colloquium/2025/Posters/30
Restricted
Available to ONU community via local IP address and ONU login.
The Effects of Vaccine Education on Those with Cardiovascular Disease
ONU McIntosh Center; Activities Room
Problem: Cardiovascular disease (CVD) is a leading cause of morbidity and mortality worldwide. Individuals with CVD are at increased risk for complications from respiratory infections such as influenza and pneumonia. Influenza and pneumococcal vaccines have been shown to reduce the incidence of these infections and associated hospitalizations in CVD patients. However, vaccine compliance remains suboptimal.
Aim: This study aims to evaluate whether implementing mandatory discharge teaching on receiving the influenza and pneumococcal vaccines in patients newly diagnosed with CVD increases vaccine compliance compared to those who do not receive educational interventions.
Methods: A prospective cohort study will be conducted involving patients with a new diagnosis of CVD. Patients will be randomly assigned to either the intervention group, where mandatory discharge teaching on the importance and benefits of receiving the influenza and pneumococcal vaccines will be provided, or the control group, where no specific discharge education will be given regarding vaccination. The primary outcome is vaccine compliance, measured by documented receipt of both vaccines within three months of hospital discharge.
Conclusion: It is anticipated that patients receiving discharge education on the vaccines will show a higher rate of vaccine compliance compared to those who do not receive such education. If the intervention group shows significantly higher vaccine compliance, this would suggest that mandatory discharge teaching on influenza and pneumococcal vaccination could be a viable strategy to improve preventive care in patients with newly diagnosed CVD. As a result, potentially reducing their risk of serious respiratory infections and related complications, including mortality.